Cargando…
Efficacy of species-specific protein antibiotics in a murine model of acute Pseudomonas aeruginosa lung infection
Protein antibiotics, known as bacteriocins, are widely produced by bacteria for intraspecies competition. The potency and targeted action of bacteriocins suggests that they could be developed into clinically useful antibiotics against highly drug resistant Gram-negative pathogens for which there are...
Autores principales: | McCaughey, Laura C., Ritchie, Neil. D., Douce, Gillian R., Evans, Thomas J., Walker, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957109/ https://www.ncbi.nlm.nih.gov/pubmed/27444885 http://dx.doi.org/10.1038/srep30201 |
Ejemplares similares
-
Discovery, characterization and in vivo activity of pyocin SD2, a protein antibiotic from Pseudomonas aeruginosa
por: McCaughey, Laura C., et al.
Publicado: (2016) -
Pyocin efficacy in a murine model of Pseudomonas aeruginosa sepsis
por: Six, Anne, et al.
Publicado: (2021) -
A murine model of early Pseudomonas aeruginosa lung disease with transition to chronic infection
por: Bayes, H. K., et al.
Publicado: (2016) -
Multiple holins contribute to extracellular DNA release in Pseudomonas aeruginosa biofilms
por: Hynen, Amelia L., et al.
Publicado: (2021) -
Interleukin-17 Is Required for Control of Chronic Lung Infection Caused by Pseudomonas aeruginosa
por: Bayes, Hannah K., et al.
Publicado: (2016)